| Net Loss per Share Attributable to Common Stockholders |
Net Loss per Share Attributable to Common Stockholders Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Because the Company reported a net loss for the three months ended March 31, 2026 and 2025, the number of shares used to calculate diluted net loss per common share is the same as the number of shares used to calculate basic net loss per common share for those periods presented because the potentially dilutive shares would have been antidilutive if included in the calculation.
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, |
|
2026 |
|
2025 |
| Numerator: |
|
|
|
| Net loss attributable to common stockholders |
$ |
(109,950) |
|
|
$ |
(82,406) |
|
| Denominator: |
|
|
|
| Weighted-average shares outstanding |
943,503,442 |
|
|
766,908,858 |
|
| Net loss per share attributable to common stockholders, basic and diluted |
$ |
(0.12) |
|
|
$ |
(0.11) |
|
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, |
|
2026 |
|
2025 |
| Common stock warrants |
14,237,783 |
|
|
28,783,069 |
|
| Unvested restricted stock awards |
555,968 |
|
|
1,001,965 |
|
Unvested restricted stock units |
47,541,477 |
|
|
35,457,317 |
|
| Options to purchase common stock |
5,740,753 |
|
|
9,030,139 |
|
| Unvested early exercised common stock options |
621,005 |
|
|
995,539 |
|
If-converted common stock from 2032 Notes (1)
|
48,634,374 |
|
|
— |
|
| Total |
117,331,360 |
|
|
75,268,029 |
|
|